NVO Stockholders Have Opportunity to Lead Novo Nordisk A/S Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
NEW YORK, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...
Fierce Biotech12h
'Not a cost-cutting exercise': Novo Nordisk CSO explains rationale behind pharma's R&D shake-up
Novo Nordisk may be reorganizing its early-stage R&D capabilities, but the Danish pharma’s chief scientific officer has ...
Lazard International Equity Select Portfolio Q4 2024 Commentary
During Q4 2024, the Lazard International Equity Select Portfolio fell 9.2% (net), lagging the MSCI All Country World ex-US ...
Lazard International Strategic Equity Portfolio Q4 2024 Commentary
During Q4 2024, the Lazard International Strategic Equity Portfolio fell 8.7% (net), modestly lagging the MSCI EAFE Index which fell 8.1%. Click here to read more.
Eli Lilly launches weight loss drug in India beating Novo Nordisk
Eli Lilly (NYSE:LLY) has launched its popular weight loss/diabetes therapy Mounjaro in India, beating its biggest rival, Novo ...